In June 2019 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete Amanda Chudoba Obrigewitch after her sample tested positive for the prohibited substances Hydrochlorothiazide without a valid TUE. After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted the provisional suspension and the sanction proposed by CCES.
The CCES established that the Athlete had a diagnosed condition and had a valid medical prescription for the use of Hydrochlorothiazide for therapeutic purposes as directed by her physician.
Although the Athlete was subsequently granted a TUE for the use of Hydrochlorothiazide, as an Athlete in the National Athlete Pool the Athlete was required to have a TUE in advance – prior to using Hydrochlorothiazide in-competition. The CCES finds that the Athlete was careless in not filing her TUE application on time.
The CCES holds that there is No Significant Fault or negligence in this case and considers the Athlete’s degree of fault to be low. Therefore the CCES decides on 3 July 2019 to impose a 1 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 21 June 2019. Under the Rules at least 50% of the sanction (2 weeks) must be served after 21 June 2019 as it ends on 5 July 2019.
